US.KVUE · Kenvue

{
  "risk": {
    "level": "Medium",
    "reason": "risk management score >= 6.5/10",
    "position": {
      "score": 1.8,
      "details": {
        "atrPct": 1.7694399129961937,
        "turnoverUsdM": 298.26393429,
        "liquidityPoints": 0.6,
        "volatilityPoints": 1.2
      }
    },
    "rrPoints": 1.6,
    "stopLevels": {
      "symbol": "US.KVUE",
      "rr_range": "1:1.0-1:2.5",
      "risk_profile": "中等",
      "stop_loss_price": 17.7392,
      "strength_details": {
        "ma_score": 1,
        "atr_score": 2.5,
        "rsi_score": 1,
        "macd_score": 1,
        "volume_score": 1
      },
      "market_adjustment": 1,
      "risk_reward_ratio": 1.4,
      "stop_loss_percent": 3.5,
      "take_profit_price": 19.3095,
      "target_multiplier": 1.6,
      "technical_strength": 1.23,
      "take_profit_percent": 5
    },
    "positionPoints": 1.8,
    "stopLossPoints": 2.4,
    "diversification": {
      "score": 2,
      "details": {
        "method": "sector concentration proxy; no portfolio holdings used",
        "sector": "Consumer Staples",
        "concentratedSectorPenalty": 0
      }
    },
    "riskRewardRatio": 1.4128764597418562,
    "stopLossPercent": 3.5388798259923875,
    "diversificationPoints": 2
  },
  "total": {
    "max": 160,
    "result": 48,
    "formula": "score_with_momentum_v2 = main_score + momentum_5d_v2_score",
    "baseScore": 47,
    "modelVersion": "cursor_18_27_news_v2_160",
    "momentum5dScore": 1
  },
  "market": {
    "ma20": 19.0165,
    "ma50": 19.1646,
    "close": 18.39,
    "prevClose": 18.74,
    "avgVolume20": 19544046,
    "volumeRatio": 0.83,
    "changePercent": -1.87
  },
  "sources": {
    "catalyst": "finnhub_news_keyword_model",
    "sentiment": "finnhub_news_keyword_model",
    "fundamentals": "fmp_stable",
    "institutional": null,
    "marketContext": "twelvedata+fred"
  },
  "barCount": 60,
  "momentum": {
    "max": 50,
    "result": 1,
    "details": {
      "ret_5d": -0.025953389830508433,
      "max_score": 50,
      "max_total": 50,
      "raw_total": 1,
      "vcp_bonus": 0,
      "vol_ratio": 0.8105105741404185,
      "ret_points": 0,
      "vol_points": 0,
      "range_ratio": 0.9446180071006941,
      "volat_points": 0,
      "day_range_pct": 0.014681892332789536,
      "model_version": "cursor_18_27_news_v2_160",
      "available_bars": 30,
      "breakout_points": 0,
      "partial_history": false,
      "pullback_points": 1,
      "breakout_vol_bonus": 0,
      "first_breakout_20d": false,
      "return_window_days": 5,
      "first_breakout_bonus": 0,
      "breakout_quality_points": 0
    },
    "formula": "Cursor_18.25 5D momentum v2 0-50",
    "modelVersion": "cursor_18_27_news_v2_160"
  },
  "scoreMax": 110,
  "composite": {
    "max": 160,
    "result": 48,
    "formula": "Cursor_18.25 ranking score v2 (score_with_momentum_v2)",
    "weights": [
      {
        "raw": 4.1,
        "label": "基本面",
        "weight": "5/110",
        "normalized": 82,
        "contribution": 4.1
      },
      {
        "raw": 6,
        "label": "資金流",
        "weight": "20/110",
        "normalized": 30,
        "contribution": 6
      },
      {
        "raw": 10.6,
        "label": "市場環境",
        "weight": "15/110",
        "normalized": 70.67,
        "contribution": 10.6
      },
      {
        "raw": 2,
        "label": "催化劑",
        "weight": "20/110",
        "normalized": 10,
        "contribution": 2
      },
      {
        "raw": 7.8,
        "label": "風險管理",
        "weight": "10/110",
        "normalized": 78,
        "contribution": 7.8
      },
      {
        "raw": 12.5,
        "label": "技術信號",
        "weight": "30/110",
        "normalized": 41.67,
        "contribution": 12.5
      },
      {
        "raw": 4,
        "label": "情緒分析",
        "weight": "10/110",
        "normalized": 40,
        "contribution": 4
      }
    ],
    "modelVersion": "cursor_18_27_news_v2_160"
  },
  "momentumMax": 50,
  "scoreStatus": "checked",
  "standard110": {
    "rating": "避免",
    "result": 47,
    "details": [
      "基本面分析總分: 4.1/5分",
      "資金流分析總分: 6/20分",
      "市場環境分析總分: 10.6/15分",
      "催化劑分析: 2/20分",
      "風險管理總分: 7.8/10分",
      "技術信號分析總分: 12.5/30分",
      "情緒分析: 4/10分",
      "共振率(僅顯示不加分): 0%"
    ],
    "formula": "基本面5 + 資金流20 + 市場環境15 + 催化劑20 + 風險管理10 + 技術信號30 + 情緒10",
    "dimensionScores": {
      "催化劑": 2,
      "基本面": 4.1,
      "資金流": 6,
      "市場環境": 10.6,
      "情緒分析": 4,
      "技術信號": 12.5,
      "風險管理": 7.8
    },
    "dimensionDetails": {
      "催化劑": {
        "max": 20,
        "grade": "較差",
        "items": {
          "catalyst": {
            "score": 2,
            "details": {
              "source": "finnhub_news_keyword_model",
              "articleCount": 4,
              "catalystCount": 0
            }
          },
          "catalystPoints": 2
        }
      },
      "基本面": {
        "max": 5,
        "grade": "優秀",
        "items": {
          "pbPoints": 0.4,
          "pePoints": 0.4,
          "epsPoints": 0.75,
          "roePoints": 0.6,
          "debtPoints": 0.4,
          "marginPoints": 0,
          "turnoverUsdM": 298.26393429,
          "volumePoints": 0.5,
          "revenuePoints": 0,
          "dividendPoints": 0.5,
          "marketCapPoints": 0.5
        },
        "source": "fmp_stable"
      },
      "資金流": {
        "max": 20,
        "grade": "較差",
        "items": {
          "cmfPoints": 0.8,
          "mfiPoints": 1.6,
          "obvPoints": 0.8,
          "vwapPoints": 0.8,
          "institutional": {
            "score": 2,
            "details": {
              "source": "optional-neutral",
              "warning": {
                "code": "INSTITUTIONAL_DATA_OPTIONAL",
                "symbol": "US.KVUE",
                "message": "Institutional ownership is unavailable; neutral 2/4 money-flow treatment used."
              },
              "optional": true,
              "holderCount": null,
              "holderPoints": 2,
              "top10ShareRatio": null,
              "concentrationPenalty": 0
            }
          },
          "institutionPoints": 2
        }
      },
      "市場環境": {
        "max": 15,
        "grade": "良好",
        "items": {
          "vix": {
            "score": 2.4,
            "details": {
              "source": "twelvedata+fred",
              "vixClose": 15.3
            }
          },
          "trend": {
            "score": 3.4,
            "details": {
              "qqq": {
                "ma20": 717.3850005500001,
                "ma50": 711.3217994399997,
                "name": "QQQ",
                "close": 718.35999,
                "points": 2
              },
              "spy": {
                "ma20": 768.6994929500001,
                "ma50": 757.5966012200001,
                "name": "SPY",
                "close": 765.96002,
                "points": 1.4
              },
              "source": "twelvedata+fred"
            }
          },
          "atrPct": 1.7694399129961937,
          "atrPoints": 4,
          "cciPoints": 0.8,
          "vixPoints": 2.4,
          "marketTrendPoints": 3.4
        }
      },
      "情緒分析": {
        "max": 10,
        "grade": "較差",
        "items": {
          "sentiment": {
            "score": 4,
            "details": {
              "source": "finnhub_news_keyword_model",
              "articleCount": 4,
              "negativeHits": 0,
              "positiveHits": 1,
              "sentimentScoreRaw": 0.6
            }
          },
          "sentimentData": {
            "raw": [
              {
                "id": 141771435,
                "url": "https://finnhub.io/api/news?id=c7fb779f54328c36dd6407d82131e651780d8d24dbeab0820fdfc8bbec803f7b",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "KVUE",
                "summary": "Kenvue's profit margins and cash flow improved in the first half, but modest sales growth, debt and uneven segment trends keep the risk-reward balanced.",
                "category": "company",
                "datetime": 1788809160,
                "headline": "Should Investors Buy KVUE as Margin Gains Offset Slow Sales Growth?"
              },
              {
                "id": 141282754,
                "url": "https://finnhub.io/api/news?id=d6e8702ffd287b3173c9163b137bb8ec42a1739ff848e40850de334af327d7ca",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "KVUE",
                "summary": "Kenvue stock has delivered a 9.3% gain year to date. Its current share price of US$18.93 still sits well below an intrinsic value estimate from a Discounted Cash Flow (DCF) model, which points to a 36.4% discount. At the same time, traditional earnings multiples suggest the shares look about fairly priced, leaving investors weighing a clear DCF upside signal against more neutral market ratios. Year to date, Kenvue is up 9.3%, indicating the market has already repriced the stock higher even...",
                "category": "company",
                "datetime": 1787292615,
                "headline": "Kenvue (KVUE) Stock Looks Cheap On Cash Flow But Fair On Earnings"
              },
              {
                "id": 141282755,
                "url": "https://finnhub.io/api/news?id=a45b9ab18c80eae5ef52d4897040a916581758913448bcfaed72ddb23667f08f",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "KVUE",
                "summary": "In August 2026, Kenvue’s Zyrtec brand launched Zyrtec Allergen Shield Spray, a drug-free nasal mist that forms a gel barrier in the nose within minutes to help block common airborne allergens like pollen, pet dander, and dust for up to six hours in adults and children aged 12 and older. This first-of-its-kind, HPMC-based spray expands Zyrtec’s toolkit toward proactive allergen defense, signaling Kenvue’s push into drug-free, preventative allergy solutions. We’ll now examine how this new...",
                "category": "company",
                "datetime": 1787271185,
                "headline": "Should Zyrtec’s New Drug-Free Allergen Shield Spray Launch Require Action From Kenvue (KVUE) Investors?"
              },
              {
                "id": 141282756,
                "url": "https://finnhub.io/api/news?id=f7e9f9af2724ae75a24bbee4208fcfc80ce1a514f2e2f949f1a3e6ffa79e11d9",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "KVUE",
                "summary": "Zyrtec Allergen Shield Spray, a new drug free nasal mist from Kenvue (KVUE), has given investors fresh product news to weigh. The launch highlights activity in the company’s Self Care allergy portfolio. See our latest analysis for Kenvue. The recent Zyrtec Allergen Shield Spray launch comes after Kenvue reported second quarter 2026 sales of US$3,955 million and net income of US$456 million on August 6, while also completing a US$439.14 million share repurchase program that covered 20,387,000...",
                "category": "company",
                "datetime": 1787235222,
                "headline": "Kenvue (KVUE) Launches Zyrtec Spray As Its Undervalued Case Faces A Fresh Test"
              }
            ],
            "raw_source": [
              {
                "id": 141951170,
                "url": "https://finnhub.io/api/news?id=75fead89f45544c493496f3562cafd83f45c34472705a519771300549f4e4def",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "KVUE",
                "summary": "KVUE's trusted brands, innovation and productivity initiatives support growth as it strengthens its consumer health portfolio and global reach.",
                "category": "company",
                "datetime": 1788878820,
                "headline": "Kenvue's Brand Strength and Innovation Strategy Support Growth"
              },
              {
                "id": 141949289,
                "url": "https://finnhub.io/api/news?id=4d692700574c5bd991de1cb46707cbbc7162de9134cc7fb87a13d812a326409e",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2182047027/image_2182047027.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "KVUE",
                "summary": "Key contributors include Infineon Technologies, Teradyne and Walmart. Learn more about key detractors.",
                "category": "company",
                "datetime": 1788861600,
                "headline": "American Century Value Fund Q2 2026 Contributors And Detractors"
              },
              {
                "id": 141772565,
                "url": "https://finnhub.io/api/news?id=5e844c2d43a8aa6c28d198fd925d3f2c06c12c9621142c58f8c7b2480fe32ab7",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "KVUE",
                "summary": "Kimberly-Clark Corporation’s (NASDAQ:KMB) proposed $40 billion takeover of Kenvue has entered another stage of regulatory review. Documents on the European Commission’s website show that Kimberly-Clark has requested EU permission to complete the transaction, which was first announced in November 2025. The deal would combine Kimberly-Clark (NASDAQ:KMB) with a large portfolio of consumer-health brands, including Tylenol, […]",
                "category": "company",
                "datetime": 1788829402,
                "headline": "Can Kimberly-Clark Turn its $40 Billion Kenvue Bet into $2.1 Billion in Savings?"
              },
              {
                "id": 141771434,
                "url": "https://finnhub.io/api/news?id=aa27da536d50efd6679bcfd77d715631ee64f99862603b3e3817532e17f0638d",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "KVUE",
                "summary": "KVUE nears its planned combination after shareholder and U.S. antitrust clearances, while margin, debt and legal risks temper the Q4 2026 outlook.",
                "category": "company",
                "datetime": 1788809280,
                "headline": "Kenvue's Kimberly-Clark Deal Nears Closing With Key Risks Still Ahead"
              },
              {
                "id": 141771435,
                "url": "https://finnhub.io/api/news?id=c7fb779f54328c36dd6407d82131e651780d8d24dbeab0820fdfc8bbec803f7b",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "KVUE",
                "summary": "Kenvue's profit margins and cash flow improved in the first half, but modest sales growth, debt and uneven segment trends keep the risk-reward balanced.",
                "category": "company",
                "datetime": 1788809160,
                "headline": "Should Investors Buy KVUE as Margin Gains Offset Slow Sales Growth?"
              },
              {
                "id": 141364398,
                "url": "https://finnhub.io/api/news?id=09d17b13a3b9623d1cbaf1c6affe0168839e4c7814c7d78cf92b2d3e5cbbcdb8",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "KVUE",
                "summary": "Deal skepticism and litigation fears still weigh on this consumer staples stalwart.",
                "category": "company",
                "datetime": 1788186900,
                "headline": "This Dividend King Just Offered a Buy-the-Dip Opportunity"
              },
              {
                "id": 141336283,
                "url": "https://finnhub.io/api/news?id=d92db7b94ab38deb8d45bd11ce337de7df789b48d477823807203626cf4038b8",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2215519735/image_2215519735.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "KVUE",
                "summary": "Dividend Aristocrats (NOBL) nearly match SPY in 2026, with top gainers, rising dividend growth, and 29 undervalued picks—see which to buy now.",
                "category": "company",
                "datetime": 1787894920,
                "headline": "Best Dividend Aristocrats For September 2026"
              },
              {
                "id": 141364399,
                "url": "https://finnhub.io/api/news?id=0cdf3bbf82fd4d3692b991366108d2d79958c3da74c34e9b945ade1fee13dd52",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "KVUE",
                "summary": "Kimberly-Clark (KMB) stock is in focus after the company named Suzana Blades as Senior Vice President and General Counsel, with a future role tied to its pending acquisition of Kenvue Inc. Kimberly-Clark shares trade at US$110.34, with the stock up 10.2% over the past 90 days and 8.8% year to date on a share price basis, even though the 1 year total shareholder return has declined 11.1%. This points to improving short term momentum alongside a weaker longer term experience for...",
                "category": "company",
                "datetime": 1787846798,
                "headline": "Kimberly Clark (KMB) Names New Legal Chief As Kenvue Deal Puts Valuation In Focus"
              },
              {
                "id": 141364401,
                "url": "https://finnhub.io/api/news?id=7d1eb0210e7bb49c050819cf974eab94fa77135ae900c69af885597380b1861d",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "KVUE",
                "summary": "Pure Strategies, a sustainability consulting firm empowering brands and retailers to realize meaningful environmental and social improvement, is offering a full day of workshops, panels, and small group discussions during Climate Week NYC. The \"Day of Action\" program, being held Wednesday, September 23, 2026, is designed to help companies advance climate and nature strategies and turn sustainability investment into measurable returns.",
                "category": "company",
                "datetime": 1787775420,
                "headline": "Pure Strategies Announces \"Day of Action\" Full Day Program during Climate Week NYC - September 23, 2026"
              },
              {
                "id": 141324202,
                "url": "https://finnhub.io/api/news?id=c710f4da94ba6b1816de5555e8b2151446aae51f52ce20fa254d5a2921bdc8fd",
                "image": "https://www.chartmill.com/images/uploads/CM_Most_Active_Stocks_Small_free_fec0650b7f.webp",
                "source": "ChartMill",
                "related": "KVUE",
                "summary": "Stay informed about the most active stocks in the S&P500 index on Wednesday's session. Discover the stocks that are generating the highest trading volume and driving market activity.",
                "category": "company",
                "datetime": 1787767501,
                "headline": "Explore the S&P500 index on Wednesday and find out which stocks are the most active in today's session."
              },
              {
                "id": 141312616,
                "url": "https://finnhub.io/api/news?id=041f861e37772b1094116dba0988f23039993625d6d2ef845d0a2ee0d16a1e4d",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/458559027/image_458559027.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "KVUE",
                "summary": "Kenvue Inc. upgraded to a soft buy as the Kimberly-Clark Corporation merger looks likely. Click for this updated look at KVUE and KMB as they seek to join.",
                "category": "company",
                "datetime": 1787599909,
                "headline": "Kenvue Deserves Some Love As Its Purchase By Kimberly-Clark Looks Imminent"
              },
              {
                "id": 141364400,
                "url": "https://finnhub.io/api/news?id=f57b06989658200ab5d2eae0097a7252b38920e5534a9d42d5ec6e6a1c7b2034",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "KVUE",
                "summary": "In a challenge brought by Kenvue Inc., BBB National Programs’ National Advertising Division determined that Hims & Hers Health, Inc. provided a reasonable basis for its comparative efficacy claim. However, the National Advertising Division (NAD) recommended that it modify or discontinue other claims regarding doctor-trusted ingredients, dermatologist recommendations, safety and side effects.New York, NY, Aug. 24, 2026 (GLOBE NEWSWIRE) -- In a challenge brought by Kenvue Inc., BBB National Progra",
                "category": "company",
                "datetime": 1787594400,
                "headline": "National Advertising Division Finds Hims & Hers Has Support for Combination Efficacy Message; Recommends Modification or Discontinuance of Other Claims"
              },
              {
                "id": 141310775,
                "url": "https://finnhub.io/api/news?id=8ebad401400c6591cbad60ecd91bb62c4623c346f30482ec02166fddb02adf4f",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2257340277/image_2257340277.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "KVUE",
                "summary": "Kenvue Inc.’s KMB buyout faces China SAMR Phase 2 antitrust review. Click for more on KVUE and how this affects whether you should invest in KVUE stock.",
                "category": "company",
                "datetime": 1787586192,
                "headline": "Kenvue: Acquisition By Kimberly-Clark Hit An Obstacle - What Now"
              },
              {
                "id": 141364402,
                "url": "https://finnhub.io/api/news?id=730a9ed2aaaaa65bb9c2e979496358c87934786262e81db479e74c94f7a9899f",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "KVUE",
                "summary": "The beauty group's repricing rests on a profit plan it controls, while the low end of its new sales guidance is no faster than the year just ended.",
                "category": "company",
                "datetime": 1787585240,
                "headline": "Estee Lauder Stock Jumped On A Bigger Margin Promise"
              },
              {
                "id": 141307500,
                "url": "https://finnhub.io/api/news?id=32b08bbe296e7cb212fd1ae7c5aebca8ee10a12f8968f1cb43ac3b54896393a6",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2260312486/image_2260312486.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "KVUE",
                "summary": "Dividend Kings beat the S&P 500 YTD, with 30 topping SPY and 25 looking undervalued with 10%+ return potential.",
                "category": "company",
                "datetime": 1787547151,
                "headline": "Best Dividend Kings: August 2026"
              },
              {
                "id": 141282754,
                "url": "https://finnhub.io/api/news?id=d6e8702ffd287b3173c9163b137bb8ec42a1739ff848e40850de334af327d7ca",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "KVUE",
                "summary": "Kenvue stock has delivered a 9.3% gain year to date. Its current share price of US$18.93 still sits well below an intrinsic value estimate from a Discounted Cash Flow (DCF) model, which points to a 36.4% discount. At the same time, traditional earnings multiples suggest the shares look about fairly priced, leaving investors weighing a clear DCF upside signal against more neutral market ratios. Year to date, Kenvue is up 9.3%, indicating the market has already repriced the stock higher even...",
                "category": "company",
                "datetime": 1787292615,
                "headline": "Kenvue (KVUE) Stock Looks Cheap On Cash Flow But Fair On Earnings"
              },
              {
                "id": 141282755,
                "url": "https://finnhub.io/api/news?id=a45b9ab18c80eae5ef52d4897040a916581758913448bcfaed72ddb23667f08f",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "KVUE",
                "summary": "In August 2026, Kenvue’s Zyrtec brand launched Zyrtec Allergen Shield Spray, a drug-free nasal mist that forms a gel barrier in the nose within minutes to help block common airborne allergens like pollen, pet dander, and dust for up to six hours in adults and children aged 12 and older. This first-of-its-kind, HPMC-based spray expands Zyrtec’s toolkit toward proactive allergen defense, signaling Kenvue’s push into drug-free, preventative allergy solutions. We’ll now examine how this new...",
                "category": "company",
                "datetime": 1787271185,
                "headline": "Should Zyrtec’s New Drug-Free Allergen Shield Spray Launch Require Action From Kenvue (KVUE) Investors?"
              },
              {
                "id": 141278128,
                "url": "https://finnhub.io/api/news?id=6ae953c0c2a0889b6642fd3164e527ee58f54d9cc09703b5237c69b976de98ca",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "KVUE",
                "summary": "Johnson & Johnson's new drugs may offset declining sales due to patent-protection losses.",
                "category": "company",
                "datetime": 1787242320,
                "headline": "Johnson & Johnson Just Sent Shareholders an Important 11-Word Message About Its Future"
              },
              {
                "id": 141282763,
                "url": "https://finnhub.io/api/news?id=adbbcf502704dea0876fa7d6c12f56918adec15fb19170df8f68192c3d1726d1",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "KVUE",
                "summary": "Panettiere's death has re-ignited calls to boycott Neutrogena, which she said ended a partnership after she spoke out about postpartum depression.",
                "category": "company",
                "datetime": 1787239528,
                "headline": "Will a Neutrogena boycott by Hayden Panettiere's fans work?"
              },
              {
                "id": 141282756,
                "url": "https://finnhub.io/api/news?id=f7e9f9af2724ae75a24bbee4208fcfc80ce1a514f2e2f949f1a3e6ffa79e11d9",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "KVUE",
                "summary": "Zyrtec Allergen Shield Spray, a new drug free nasal mist from Kenvue (KVUE), has given investors fresh product news to weigh. The launch highlights activity in the company’s Self Care allergy portfolio. See our latest analysis for Kenvue. The recent Zyrtec Allergen Shield Spray launch comes after Kenvue reported second quarter 2026 sales of US$3,955 million and net income of US$456 million on August 6, while also completing a US$439.14 million share repurchase program that covered 20,387,000...",
                "category": "company",
                "datetime": 1787235222,
                "headline": "Kenvue (KVUE) Launches Zyrtec Spray As Its Undervalued Case Faces A Fresh Test"
              },
              {
                "id": 141282767,
                "url": "https://finnhub.io/api/news?id=059ca06eb53a909a27ad9eb14e946821ac0e6d252bd14713a5cb17ac4352d1be",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "KVUE",
                "summary": "Hygiene and health company Essity has entered into an agreement to acquire Kenvue's feminine care business in Brazil, including the market-leading brands Carefree, Sempre Livre and o.b. The purchase price amounts to USD 284m (approximately SEK 2.7bn) on a cash and debt-free basis. The acquisition strengthens Essity's position as a market leader in feminine care in Latin America.",
                "category": "company",
                "datetime": 1787198760,
                "headline": "Essity acquires feminine care business in Brazil"
              },
              {
                "id": 141261729,
                "url": "https://finnhub.io/api/news?id=c88cc7e7cc91f6d0020d7de624a2c351fd92acbfd3808ec26302e04d766c0a55",
                "image": "",
                "source": "Benzinga",
                "related": "KVUE",
                "summary": "https://www.essity.com/media/press-release/essity-acquires-feminine-care-business-in-brazil/9dd724cebbb532f5/",
                "category": "company",
                "datetime": 1787144784,
                "headline": "Essity Strikes Agreement To Acquire Kenvue's Feminine Care Operations In Brazil For $284M"
              },
              {
                "id": 141217703,
                "url": "https://finnhub.io/api/news?id=12de485133966863736ada6379090d41e2c92768a4b0512f9d46356884a13179",
                "image": "",
                "source": "Benzinga",
                "related": "KVUE",
                "summary": "- Reuters ",
                "category": "company",
                "datetime": 1786710903,
                "headline": "South Africa's Competition Tribunal Says Deal Between Kimberly-Clark Corporation And Kenvue Approved With Conditions"
              },
              {
                "id": 141215528,
                "url": "https://finnhub.io/api/news?id=74bcdf075cf3a7f5241aae00593ab560da48aec4024d0dd78a861672eaa4d254",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "KVUE",
                "summary": "Personal care products provider Kimberly-Clark Corporation (NYSE:KMB)’s shares are down by 17% over the past year and are up by 9% year-to-date. It is currently undergoing a major transformation through acquiring Kenvue. Cramer has discussed Kimberly-Clark Corporation (NYSE:KMB)’s acquisition several times and linked its performance with consumer goods giant Procter & Gamble. In his morning […]",
                "category": "company",
                "datetime": 1786694517,
                "headline": "Jim Cramer Said Kimberly-Clark Corporation (NYSE:KMB) + Kenvue Could Take On P&G – But Is He Right?"
              },
              {
                "id": 141205703,
                "url": "https://finnhub.io/api/news?id=159108e90cdd7f4ecef85c2c3fa07bcd7889d5cafe7e450000dc2465f71907dc",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "KVUE",
                "summary": "Kimberly-Clark Corporation (NASDAQ: KMB) today announced the appointment of Suzana Blades as Senior Vice President and General Counsel, effective September 1, 2026. She will report to Jeff Melucci, Chief Strategy, Business Development and Administrative Officer, and will become a member of Kimberly-Clark's Executive Leadership Team.",
                "category": "company",
                "datetime": 1786627500,
                "headline": "Kimberly-Clark Appoints Suzana Blades as Senior Vice President and General Counsel"
              },
              {
                "id": 141202291,
                "url": "https://finnhub.io/api/news?id=76d517a10585cab2c26f64a1e56e8cb30a507d567723c96c47cc86eec4a2f371",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "KVUE",
                "summary": "KVUE's Q2 sales and earnings miss estimates, but organic growth improved as Skin Health and Beauty led a broader recovery.",
                "category": "company",
                "datetime": 1786555860,
                "headline": "Kenvue Q2 Deep Dive: Assessing Financial Metrics & Growth Prospects"
              },
              {
                "id": 141192992,
                "url": "https://finnhub.io/api/news?id=300243f926ab59a86564b109878e1e9a1298e5fbdd0e3a9d1b41c2dc345f4ae9",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/487834119/image_487834119.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "KVUE",
                "summary": "Kimberly-Clark looks good, supported by a strong innovation pipeline, international growth, and the Kenvue acquisition. See why I rate KMB stock a Buy.",
                "category": "company",
                "datetime": 1786529421,
                "headline": "Kimberly-Clark: Temporary Headwinds, Strong Innovation And Kenvue Synergies Support A Buy"
              },
              {
                "id": 141190121,
                "url": "https://finnhub.io/api/news?id=6122dcbbe887770943e505b8e118b1a6814c928f257ef65b6a02dcccc21b63a2",
                "image": "",
                "source": "SeekingAlpha",
                "related": "KVUE",
                "summary": "",
                "category": "company",
                "datetime": 1786485283,
                "headline": "Tracking AMG's Yacktman Asset Management Portfolio - Q2 2026 Update"
              },
              {
                "id": 141197679,
                "url": "https://finnhub.io/api/news?id=ba6a24e91c59e9e5a733c345d867f673e857d079db042d4aeadb40eeefae14a8",
                "image": "",
                "source": "Benzinga",
                "related": "KVUE",
                "summary": "UBS  analyst Peter Grom   maintains Kenvue (NYSE:KVUE) with a Neutral and lowers the price target from $20 to $19.",
                "category": "company",
                "datetime": 1786467602,
                "headline": "UBS Maintains Neutral on Kenvue, Lowers Price Target to $19"
              },
              {
                "id": 141184813,
                "url": "https://finnhub.io/api/news?id=c8fff2e1135db913b49c4288b3803f729e59553ba605f811ab444cbc07d6ab7b",
                "image": "https://cdn.benzinga.com/files/images/story/2026/08/11/Policy-Changes-Add-Pressure.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "KVUE",
                "summary": "President Donald Trump signed an order Monday limiting core childhood vaccine recommendations to 11 vaccines.",
                "category": "company",
                "datetime": 1786402887,
                "headline": "Trump Cuts Core Childhood Vaccine Recommendations to 11, Bill Cassidy Says 'This Executive Order Is Wrong'"
              }
            ],
            "data_source": "finnhub_news_keyword_model",
            "article_count": 4,
            "negative_hits": 0,
            "positive_hits": 1,
            "recomputed_at_score": true,
            "sentiment_score_raw": 0.6,
            "source_article_count": 30,
            "discarded_article_count": 26
          },
          "sentimentPoints": 4
        }
      },
      "技術信號": {
        "max": 30,
        "raw": 12.5,
        "grade": "較差",
        "items": {
          "bbPoints": 1.8,
          "adxPoints": 3,
          "sarPoints": 1.2000000000000002,
          "vcpPoints": 1,
          "macdPoints": 0.8,
          "vcpPayload": {
            "vcp_pass": false,
            "vcp_score": 1,
            "vcp_reason": "跌縮量(近10日4日)；靠近20日高位；Ready=N；Confirm=N",
            "vcp_metrics": {
              "up_days": 1,
              "vol_ref": 21273540,
              "down_days": 8,
              "vcp_ready": false,
              "above_ma50": false,
              "avg_vol_10": 20249140,
              "avg_vol_20": 20010610,
              "avg_vol_30": 21273540,
              "range_pct_10": 0.04730831973898844,
              "range_pct_20": 0.049483414899401855,
              "range_pct_30": 0.07591082109842309,
              "up_expand_ok": false,
              "lookback_used": 59,
              "near_20d_high": true,
              "contraction_ok": false,
              "down_shrink_ok": true,
              "up_expand_days": 0,
              "breakout_20d_ok": false,
              "vol_ratio_10_30": 0.9518462841633315,
              "dist_to_20d_high": 0.05981595092024531,
              "down_shrink_days": 4,
              "breakout_level_20d": 19.56,
              "vcp_breakout_confirm": false,
              "contraction_ratio_10_30": 0.6232091690544391
            },
            "vcp_name_en": "Volatility Contraction Pattern",
            "vcp_name_zh": "波動收縮形態",
            "vol_contraction": false
          },
          "kdjAdxPoints": 0.5,
          "rsiKdjPoints": 2.4,
          "volumeWeight": 2,
          "maCrossPoints": 0,
          "shortRsiPoints": 0,
          "shortMacdPoints": 0.4,
          "volConfirmPoints": 0.6,
          "volumePointsTechnical": 0.8
        }
      },
      "風險管理": {
        "max": 10,
        "grade": "良好",
        "items": {
          "position": {
            "score": 1.8,
            "details": {
              "atrPct": 1.7694399129961937,
              "turnoverUsdM": 298.26393429,
              "liquidityPoints": 0.6,
              "volatilityPoints": 1.2
            }
          },
          "rrPoints": 1.6,
          "stopLevels": {
            "symbol": "US.KVUE",
            "rr_range": "1:1.0-1:2.5",
            "risk_profile": "中等",
            "stop_loss_price": 17.7392,
            "strength_details": {
              "ma_score": 1,
              "atr_score": 2.5,
              "rsi_score": 1,
              "macd_score": 1,
              "volume_score": 1
            },
            "market_adjustment": 1,
            "risk_reward_ratio": 1.4,
            "stop_loss_percent": 3.5,
            "take_profit_price": 19.3095,
            "target_multiplier": 1.6,
            "technical_strength": 1.23,
            "take_profit_percent": 5
          },
          "positionPoints": 1.8,
          "stopLossPoints": 2.4,
          "diversification": {
            "score": 2,
            "details": {
              "method": "sector concentration proxy; no portfolio holdings used",
              "sector": "Consumer Staples",
              "concentratedSectorPenalty": 0
            }
          },
          "riskRewardRatio": 1.4128764597418562,
          "stopLossPercent": 3.5388798259923875,
          "diversificationPoints": 2
        }
      }
    }
  },
  "modelVersion": "cursor_18_27_news_v2_160",
  "providerErrors": [],
  "rankingScoreMax": 160,
  "dataCompleteness": {
    "complete": true,
    "missingFields": [],
    "optionalInputs": [
      "institutionalData"
    ],
    "requiredInputs": [
      "fundamentals",
      "marketContext.VIX",
      "marketContext.SPY",
      "marketContext.QQQ",
      "catalystData",
      "sentimentData",
      "ATR",
      "sector"
    ],
    "optionalInputWarnings": []
  },
  "technicalIndicators": {
    "adx": 85.71,
    "atr": {
      "atr": 0.3254,
      "rule": "ATR / current price; lower volatility scores higher",
      "score": 8,
      "atr_pct": 1.77
    },
    "cci": {
      "rule": "Cursor_18.24 CCI bands",
      "level": "超買或超賣風險",
      "score": 2,
      "value": -232.33
    },
    "cmf": {
      "rule": "Cursor_18.24 CMF bands",
      "level": "派發",
      "score": 2,
      "value": -0.1719
    },
    "kdj": {
      "d": 27.95,
      "j": -6.66,
      "k": 16.41,
      "rule": "Cursor_18.24 K/D cross",
      "score": 0,
      "signal": "死叉"
    },
    "mfi": {
      "rule": "Cursor_18.24 MFI bands",
      "level": "弱流入",
      "score": 4,
      "value": 43.22
    },
    "obv": {
      "rule": "Cursor_18.24 recent_slope vs previous_slope",
      "score": 2,
      "trend": "資金流出",
      "value": -31034711,
      "recentSlope": -14280291.1,
      "previousSlope": 3130330
    },
    "rsi": 42.76,
    "sar": {
      "rule": "Cursor_18.24 Parabolic SAR",
      "score": 4,
      "trend": "下降",
      "value": 19.6026,
      "position": "SAR喺價上",
      "distancePct": 6.59,
      "previousTrend": "下降"
    },
    "ma50": 19.1646,
    "macd": {
      "macd": -0.10115612020072007,
      "trend": "看跌",
      "signal": -0.034163211099150284,
      "histogram": -0.06699290910156978
    },
    "vwap": {
      "rule": "Cursor_18.24 VWAP 20D consecutive close",
      "score": 2,
      "value": 19.0132,
      "position": "<VWAP",
      "consecutiveAbove": 0
    },
    "volume": {
      "rule": "Cursor_18.24 volume ratio",
      "level": "無力",
      "ratio": 0.83,
      "score": 4,
      "avgVolume": 19544046,
      "currentVolume": 16218811
    },
    "derived": {
      "ma20": 19.0165,
      "ma50": 19.1646,
      "prevClose": 18.74,
      "avgVolume10": 20260821,
      "avgVolume20": 19544046,
      "changePercent": -1.87,
      "avgVolumeForScore": 19544046
    },
    "ma_cross": {
      "ma20": 19.0165,
      "ma50": 19.1646,
      "rule": "Cursor_18.24 MA20/MA50 cross",
      "cross": "熊勢",
      "score": 0,
      "prevMa20": 19.0485,
      "prevMa50": 19.1794,
      "spreadPct": 0.77,
      "isVolumeBreakout": false
    },
    "bollinger": {
      "lower": 18.5403,
      "upper": 19.4927,
      "position": "下半部"
    },
    "rsi_short": 24.68,
    "macd_short": {
      "macd": 0,
      "trend": "中性",
      "signal": 0,
      "histogram": 0
    },
    "volume_ratio": {
      "ratio": 0.83
    }
  }
}

{
  "close": 18.39,
  "volume": 16218811,
  "changePercent": -1.87
}